Results from Real-World, Long-Term Treatment Persistence with LEQEMBI(R) (lecanemab-irmb) in the ...

Results from Real-World, Long-Term Treatment Persistence with LEQEMBI(R) (lecanemab-irmb) in the United States Presented at AD/PD(TM) 2026  ACN Newswire

ADI - UN Member States recognise dementia as a leading NCD - Alzheimer's Disease International (ADI)

ADI - UN Member States recognise dementia as a leading NCD  Alzheimer's Disease International (ADI)

Biogen forecasts annual profit above estimates as Leqembi sales pick up - Yahoo Finance

Biogen forecasts annual profit above estimates as Leqembi sales pick up  Yahoo Finance

The TREM2 agonistic antibody AL002 in early Alzheimer’s disease: a phase 2 randomized trial - Nature

The TREM2 agonistic antibody AL002 in early Alzheimer’s disease: a phase 2 randomized trial  Nature

Long-term effects of forty-hertz auditory stimulation as a treatment of Alzheimer’s disease: Insi...

Long-term effects of forty-hertz auditory stimulation as a treatment of Alzheimer’s disease: Insights from an aged monkey model study  PNAS

Parkinson's Protein Could Help Explain Alzheimer's Gender Imbalance - ScienceAlert

Parkinson's Protein Could Help Explain Alzheimer's Gender Imbalance  ScienceAlert

A brain game may cut risk of Alzheimer's disease by 25%, study finds - PhillyVoice

A brain game may cut risk of Alzheimer's disease by 25%, study finds  PhillyVoice

AI detects Alzheimer’s on brain perfusion SPECT scans - AuntMinnie

AI detects Alzheimer’s on brain perfusion SPECT scans  AuntMinnie

The Science Behind Chris Hemsworth’s Alzheimer’s Documentary - Time Magazine

The Science Behind Chris Hemsworth’s Alzheimer’s Documentary  Time Magazine

As Chris Hemsworth lets fans into his family's struggle with Alzheimer's, he's curious how the me...

As Chris Hemsworth lets fans into his family's struggle with Alzheimer's, he's curious how the mental health revelation will impact his career. Read more below.  Facebook

Chris Hemsworth worried how revealing his Alzheimer's risk would affect his career as a Marvel st...

Chris Hemsworth worried how revealing his Alzheimer's risk would affect his career as a Marvel star  Entertainment Weekly

Why ‘vulnerable’ Chris Hemsworth hesitated to share his Alzheimer’s risk - Page Six

Why ‘vulnerable’ Chris Hemsworth hesitated to share his Alzheimer’s risk  Page Six

Simple Lifelong Habits Can Cut Your Alzheimer's Risk by 38%, Study Finds - ScienceAlert

Simple Lifelong Habits Can Cut Your Alzheimer's Risk by 38%, Study Finds  ScienceAlert

Eisai Listed as a Global 100 Most Sustainable Corporation for the Tenth Time - ACN Newswire

Eisai Listed as a Global 100 Most Sustainable Corporation for the Tenth Time  ACN Newswire

First-of-Its-Kind Map of Alzheimer's Reveals Hidden Gene Activity - ScienceAlert

First-of-Its-Kind Map of Alzheimer's Reveals Hidden Gene Activity  ScienceAlert

Bacteria at The Back of Your Eye May Be Linked With Alzheimer's Progress - ScienceAlert

Bacteria at The Back of Your Eye May Be Linked With Alzheimer's Progress  ScienceAlert

Scientists Identify 'Master Regulator' Behind Alzheimer's Problematic Proteins - ScienceAlert

Scientists Identify 'Master Regulator' Behind Alzheimer's Problematic Proteins  ScienceAlert

Cancer May Emit Signals That Protect The Brain Against Alzheimer's - ScienceAlert

Cancer May Emit Signals That Protect The Brain Against Alzheimer's  ScienceAlert

Blood Sugar Spikes Linked With 69% Higher Risk of Alzheimer's - ScienceAlert

Blood Sugar Spikes Linked With 69% Higher Risk of Alzheimer's  ScienceAlert

Gut Inflammation Link to Alzheimer's Disease Confirmed Once Again - ScienceAlert

Gut Inflammation Link to Alzheimer's Disease Confirmed Once Again  ScienceAlert

Alzheimer’s: Future Diagnoses May Come Via ‘Simple’ Skin Biopsy - Newsweek

Alzheimer’s: Future Diagnoses May Come Via ‘Simple’ Skin Biopsy  Newsweek

Your Samsung phone and watch could soon warn you of Alzheimer's disease - Android Authority

Your Samsung phone and watch could soon warn you of Alzheimer's disease  Android Authority

Combined PET scans predict the progression of Alzheimer’s disease - AuntMinnie

Combined PET scans predict the progression of Alzheimer’s disease  AuntMinnie

Alzheimer’s: Omega-3 Fatty Acids May Protect Women From Disease - Newsweek

Alzheimer’s: Omega-3 Fatty Acids May Protect Women From Disease  Newsweek

Alzheimer’s family mystery: How did one woman avoid the disease? - futurity.org

Alzheimer’s family mystery: How did one woman avoid the disease?  futurity.org

Utility of Digital Twin AI-Generated Models to Improve Patient Selection in Alzheimer Trials - Ne...

Utility of Digital Twin AI-Generated Models to Improve Patient Selection in Alzheimer Trials  Neurology Live

Reduced non–rapid eye movement sleep is associated with tau pathology in early Alzheimer’s diseas...

Reduced non–rapid eye movement sleep is associated with tau pathology in early Alzheimer’s disease  Science | AAAS

Alzheimer’s: Scientists Discover What Sparks Disease - Newsweek

Alzheimer’s: Scientists Discover What Sparks Disease  Newsweek

In vivo validation of late‐onset Alzheimer's disease genetic risk factors - Wiley

In vivo validation of late‐onset Alzheimer's disease genetic risk factors  Wiley

Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila: A potential model for A...

Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila: A potential model for Alzheimer's disease  PNAS

Good oral health may help protect against Alzheimer’s - Harvard Health

Good oral health may help protect against Alzheimer’s  Harvard Health

‘That’s the real…’: 18-year-old starts his day at 3 am to run AI startup tackling Alzheimer’s - T...

‘That’s the real…’: 18-year-old starts his day at 3 am to run AI startup tackling Alzheimer’s  The Financial Express

Duke, UNC Awarded Grant to Establish Joint Alzheimer’s Disease Research Center - UNC Health

Duke, UNC Awarded Grant to Establish Joint Alzheimer’s Disease Research Center  UNC Health

Rodent models for Alzheimer disease - Nature

Rodent models for Alzheimer disease  Nature

Investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s, ...

Investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s, initial analysis indicates  WashU Medicine

Alzheimer’s Disease at a Glance - National Institutes of Health (.gov)

Alzheimer’s Disease at a Glance  National Institutes of Health (.gov)

Lecanemab in Early Alzheimer’s Disease - The New England Journal of Medicine

Lecanemab in Early Alzheimer’s Disease  The New England Journal of Medicine

Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzh...

Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer’s Disease  Nature

Alzheimer’s and Prevention: Who Would Have Thought? - NewYork-Presbyterian

Alzheimer’s and Prevention: Who Would Have Thought?  NewYork-Presbyterian

Solanezumab: too late in mild Alzheimer's disease? - The Lancet

Solanezumab: too late in mild Alzheimer's disease?  The Lancet

Conquering Alzheimer’s: a look at the therapies of the future - Nature

Conquering Alzheimer’s: a look at the therapies of the future  Nature

Eisai Announces Status Relating to Acquisition of Own Shares - ACN Newswire

Eisai Announces Status Relating to Acquisition of Own Shares  ACN Newswire

ADI - The Lancet launches important new guidance on dementia risk reduction - Alzheimer's Disease...

ADI - The Lancet launches important new guidance on dementia risk reduction  Alzheimer's Disease International (ADI)

Warnings over shock dementia revelations from ancestry DNA tests - The Guardian

Warnings over shock dementia revelations from ancestry DNA tests  The Guardian

Can blocking enzymes reverse Alzheimer’s memory loss? - futurity.org

Can blocking enzymes reverse Alzheimer’s memory loss?  futurity.org

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation - The Lancet

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation  The Lancet

Eisai: Regarding Discontinuation of Administration of "Tazverik(R) Tablets 200mg" (tazemetostat h...

Eisai: Regarding Discontinuation of Administration of "Tazverik(R) Tablets 200mg" (tazemetostat hydrobromide)  ACN Newswire

Toxic air pollution particles found in human brains - The Guardian

Toxic air pollution particles found in human brains  The Guardian

Method created to better remove protein causing Alzheimer’s - 朝日新聞

Method created to better remove protein causing Alzheimer’s  朝日新聞

A new culprit of cognitive decline in Alzheimer's disease - Medical Xpress

A new culprit of cognitive decline in Alzheimer's disease  Medical Xpress

Eisai to Launch Chocola BB Sparkling Kiwi & Lemon Flavor - ACN Newswire

Eisai to Launch Chocola BB Sparkling Kiwi & Lemon Flavor  ACN Newswire

Eisai Launches Awareness Campaign on Importance of Sleep Through "Pokemon Sleep" Collaboration - ...

Eisai Launches Awareness Campaign on Importance of Sleep Through "Pokemon Sleep" Collaboration  ACN Newswire

Novo's older obesity drug shows biological effect on Alzheimer's patients in small trial - Reuters

Novo's older obesity drug shows biological effect on Alzheimer's patients in small trial  Reuters

Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT ...

Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation  ACN Newswire

FDA clears new Alzheimer's features for Siemens' syngo.PET software - AuntMinnie

FDA clears new Alzheimer's features for Siemens' syngo.PET software  AuntMinnie

They Have Alzheimer’s. This Clinical Trial May Be a Last Hope. (Published 2021) - The New York Times

They Have Alzheimer’s. This Clinical Trial May Be a Last Hope. (Published 2021)  The New York Times

Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplu...

Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan  ACN Newswire

Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Fac...

Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Factor (FGF) Receptor Selective Tyrosine Kinase Inhibitor Tasurgratinib in Greater China Region (Mainland China, Hong Kong, Macau, and Taiwan) with SciClone  ACN Newswire

Could tear proteins be biomarkers for Alzheimer disease? - Nature

Could tear proteins be biomarkers for Alzheimer disease?  Nature

Eisai: Update on the Co-Promotion of the Oral Antifungal Agent Nailin Capsules 100mg in Japan - A...

Eisai: Update on the Co-Promotion of the Oral Antifungal Agent Nailin Capsules 100mg in Japan  ACN Newswire

Sugar’s “tipping point” link to Alzheimer’s disease revealed - University of Bath

Sugar’s “tipping point” link to Alzheimer’s disease revealed  University of Bath

A big Alzheimer’s drug trial now wrapping up could offer real hope — or crush it - statnews.com

A big Alzheimer’s drug trial now wrapping up could offer real hope — or crush it  statnews.com

QST Photo Gallery - qst.go.jp

QST Photo Gallery  qst.go.jp

AI can spot signs of Alzheimer’s before your family does - MIT Technology Review

AI can spot signs of Alzheimer’s before your family does  MIT Technology Review

Alzheimer’s Disease Linked to Exposure to Aluminum - SciTechDaily

Alzheimer’s Disease Linked to Exposure to Aluminum  SciTechDaily

RETRACTED ARTICLE: A needle from the haystack - Nature

RETRACTED ARTICLE: A needle from the haystack  Nature

This Gene Increases the Risk of Alzheimer’s. Scientists Finally Know Why - SingularityHub

This Gene Increases the Risk of Alzheimer’s. Scientists Finally Know Why  SingularityHub

How to talk about finances with a loved one living with Alzheimer's disease - TD Stories

How to talk about finances with a loved one living with Alzheimer's disease  TD Stories

Eisai to Launch In-House Developed New Anti-insomnia Drug Dayvigo (Lemborexant) with Indication f...

Eisai to Launch In-House Developed New Anti-insomnia Drug Dayvigo (Lemborexant) with Indication for Insomnia in Japan  ACN Newswire

Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO(R) (Lemborexant) in China - ACN News...

Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO(R) (Lemborexant) in China  ACN Newswire

Are we facing an Alzheimer’s armageddon? - statnews.com

Are we facing an Alzheimer’s armageddon?  statnews.com

Eisai to Take over Manufacturing and Marketing Approval for Equfina 50mg Tablets (Safinamide Mesi...

Eisai to Take over Manufacturing and Marketing Approval for Equfina 50mg Tablets (Safinamide Mesilate) in Japan from Meiji Seika Pharma  ACN Newswire

Disclosure of APOE Genotype for Risk of Alzheimer's Disease - The New England Journal of Medicine

Disclosure of APOE Genotype for Risk of Alzheimer's Disease  The New England Journal of Medicine

IPMAR: major new cellular model platform launched to transform understanding of risk factors for ...

IPMAR: major new cellular model platform launched to transform understanding of risk factors for Alzheimer’s disease  UK DRI

Gene May Link Diabetes and Alzheimer’s - Neuroscience News

Gene May Link Diabetes and Alzheimer’s  Neuroscience News

'Major breakthrough': Landmark study shows best signs yet that Alzheimer's can be slowed - ABC News

'Major breakthrough': Landmark study shows best signs yet that Alzheimer's can be slowed  ABC News

Eisai to Launch "Chocola BB Gold Rich" Highest Combination of Active Ingredients in Chocola BB Se...

Eisai to Launch "Chocola BB Gold Rich" Highest Combination of Active Ingredients in Chocola BB Series  ACN Newswire

認知症治療薬：市場洞察・競合情勢・市場予測 (～2032年) - グローバルインフォメーション - 市場調査レ...

認知症治療薬：市場洞察・競合情勢・市場予測 (～2032年)  グローバルインフォメーション - 市場調査レポート